Enanta Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.8M | 187k | 9.41 |
| 2023-09-30 | $3.3M | 292k | 11.17 |
| 2023-06-30 | $5.1M | 239k | 21.40 |
| 2023-03-31 | $9.3M | 230k | 40.44 |
| 2022-12-31 | $11M | 235k | 46.52 |
| 2022-06-30 | $6.5M | 138k | 47.27 |
| 2022-03-31 | $7.2M | 101k | 71.18 |
| 2021-12-31 | $8.9M | 120k | 74.78 |
| 2021-09-30 | $5.8M | 102k | 56.81 |
| 2021-03-31 | $6.7M | 136k | 49.32 |
| 2020-12-31 | $6.8M | 161k | 42.10 |
| 2020-09-30 | $15M | 337k | 45.78 |
| 2020-06-30 | $18M | 364k | 50.21 |
| 2019-12-31 | $21M | 335k | 61.78 |
| 2019-09-30 | $16M | 273k | 60.08 |
| 2019-06-30 | $15M | 177k | 84.38 |
| 2019-03-31 | $14M | 144k | 95.52 |
| 2018-12-31 | $16M | 219k | 70.82 |
| 2018-09-30 | $14M | 158k | 85.46 |
| 2018-06-30 | $14M | 121k | 115.91 |
| 2018-03-31 | $13M | 159k | 80.91 |
| 2017-12-31 | $6.5M | 110k | 58.67 |
| 2017-09-30 | $3.9M | 84k | 46.80 |
| 2017-06-30 | $3.0M | 84k | 35.98 |
| 2017-03-31 | $1.8M | 59k | 30.79 |
| 2016-12-31 | $2.8M | 82k | 33.50 |
| 2016-09-30 | $564k | 21k | 26.59 |
| 2016-03-31 | $233k | 7.9k | 29.41 |
| 2015-12-31 | $647k | 20k | 33.03 |
| 2015-06-30 | $1.4M | 31k | 45.00 |
| 2015-03-31 | $1.4M | 45k | 30.63 |
| 2014-12-31 | $6.9M | 135k | 50.87 |
| 2013-12-31 | $260k | 9.5k | 27.25 |
| 2013-09-30 | $220k | 9.6k | 22.96 |
| 2013-06-30 | $242k | 14k | 17.70 |